2.Computer-aided drug design symposium and workshop abstract book
MetadataShow full item record
The focus of the symposium is to bring together academia and industry with an interest in the validation of novel biomolecule targets to treat disease with an unmet clinical need and in applying computational technologies towards the discovery and development of potential small molecule drugs. The main goal of the symposium is to forge interdisciplinary and trans-sectoral connections to foster novel drug discovery projects. With this goal in mind we have a wide target audience spanning the fields of chemistry, biology, medicine, pharmacy, computational design and beyond. We wish to create an environment where large/ SME pharmaceutical and biotechnology companies, and academics can more readily appreciate how each sector contributes to drug discovery research and encourage closer collaboration. While the scientific meeting will be guided by experts in the field of CADD, talks will be framed towards illustrating how chemistry – biology – design can synergistically interact with each other to bridge into the realm of medicine. We encourage early stage researchers who are not working on CADD projects to submit speaker/poster abstracts so that they can present their projects and stimulate discussion with other attendees. During the session discussions we expect the participants to find the answer to the question “how can computational drug design help me?” CADD approaches are widely used in academia and by SMEs, pharmaceutical and biotechnology companies. A selection of successful applications of CADD includes the FDA approval of Captopril, Dorzolamide, Saquinavir, Zanamivir, Oseltamivir and Aliskiren. An aim of this symposium is to discover how these technologies can help with your project.